Delivering systems pharmacogenomics towards precision medicine through mathematics

Yaqun Wang, Ningtao Wang, Jianxin Wang, Zhong Wang, Rongling Wu

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The latest developments of pharmacology in the post-genomic era foster the emergence of new biomarkers that represent the future of drug targets. To identify these biomarkers, we need a major shift from traditional genomic analyses alone, moving the focus towards systems approaches to elucidating genetic variation in biochemical pathways of drug response. Is there any general model that can accelerate this shift via a merger of systems biology and pharmacogenomics? Here we describe a statistical framework for mapping dynamic genes that affect drug response by incorporating its pharmacokinetic and pharmacodynamic pathways. This framework is expanded to shed light on the mechanistic and therapeutic differences of drug response based on pharmacogenetic information, coupled with genomic, proteomic and metabolic data, allowing novel therapeutic targets and genetic biomarkers to be characterized and utilized for drug discovery.

Original languageEnglish (US)
Pages (from-to)905-911
Number of pages7
JournalAdvanced Drug Delivery Reviews
Volume65
Issue number7
DOIs
StatePublished - Jun 30 2013

Fingerprint

Precision Medicine
Mathematics
Pharmacogenetics
Biomarkers
Pharmaceutical Preparations
Systems Biology
Chromosome Mapping
Drug Discovery
Proteomics
Pharmacokinetics
Pharmacology
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Wang, Yaqun ; Wang, Ningtao ; Wang, Jianxin ; Wang, Zhong ; Wu, Rongling. / Delivering systems pharmacogenomics towards precision medicine through mathematics. In: Advanced Drug Delivery Reviews. 2013 ; Vol. 65, No. 7. pp. 905-911.
@article{3d356b6814b64d2c969f12e2c8653b7c,
title = "Delivering systems pharmacogenomics towards precision medicine through mathematics",
abstract = "The latest developments of pharmacology in the post-genomic era foster the emergence of new biomarkers that represent the future of drug targets. To identify these biomarkers, we need a major shift from traditional genomic analyses alone, moving the focus towards systems approaches to elucidating genetic variation in biochemical pathways of drug response. Is there any general model that can accelerate this shift via a merger of systems biology and pharmacogenomics? Here we describe a statistical framework for mapping dynamic genes that affect drug response by incorporating its pharmacokinetic and pharmacodynamic pathways. This framework is expanded to shed light on the mechanistic and therapeutic differences of drug response based on pharmacogenetic information, coupled with genomic, proteomic and metabolic data, allowing novel therapeutic targets and genetic biomarkers to be characterized and utilized for drug discovery.",
author = "Yaqun Wang and Ningtao Wang and Jianxin Wang and Zhong Wang and Rongling Wu",
year = "2013",
month = "6",
day = "30",
doi = "10.1016/j.addr.2013.03.002",
language = "English (US)",
volume = "65",
pages = "905--911",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "7",

}

Delivering systems pharmacogenomics towards precision medicine through mathematics. / Wang, Yaqun; Wang, Ningtao; Wang, Jianxin; Wang, Zhong; Wu, Rongling.

In: Advanced Drug Delivery Reviews, Vol. 65, No. 7, 30.06.2013, p. 905-911.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Delivering systems pharmacogenomics towards precision medicine through mathematics

AU - Wang, Yaqun

AU - Wang, Ningtao

AU - Wang, Jianxin

AU - Wang, Zhong

AU - Wu, Rongling

PY - 2013/6/30

Y1 - 2013/6/30

N2 - The latest developments of pharmacology in the post-genomic era foster the emergence of new biomarkers that represent the future of drug targets. To identify these biomarkers, we need a major shift from traditional genomic analyses alone, moving the focus towards systems approaches to elucidating genetic variation in biochemical pathways of drug response. Is there any general model that can accelerate this shift via a merger of systems biology and pharmacogenomics? Here we describe a statistical framework for mapping dynamic genes that affect drug response by incorporating its pharmacokinetic and pharmacodynamic pathways. This framework is expanded to shed light on the mechanistic and therapeutic differences of drug response based on pharmacogenetic information, coupled with genomic, proteomic and metabolic data, allowing novel therapeutic targets and genetic biomarkers to be characterized and utilized for drug discovery.

AB - The latest developments of pharmacology in the post-genomic era foster the emergence of new biomarkers that represent the future of drug targets. To identify these biomarkers, we need a major shift from traditional genomic analyses alone, moving the focus towards systems approaches to elucidating genetic variation in biochemical pathways of drug response. Is there any general model that can accelerate this shift via a merger of systems biology and pharmacogenomics? Here we describe a statistical framework for mapping dynamic genes that affect drug response by incorporating its pharmacokinetic and pharmacodynamic pathways. This framework is expanded to shed light on the mechanistic and therapeutic differences of drug response based on pharmacogenetic information, coupled with genomic, proteomic and metabolic data, allowing novel therapeutic targets and genetic biomarkers to be characterized and utilized for drug discovery.

UR - http://www.scopus.com/inward/record.url?scp=84879551759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879551759&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2013.03.002

DO - 10.1016/j.addr.2013.03.002

M3 - Review article

C2 - 23523629

AN - SCOPUS:84879551759

VL - 65

SP - 905

EP - 911

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 7

ER -